03/28/08 - TyRx Pharma, Inc. Announces the Appointment of
Gary Young, PharmD, MBA as Vice President, Marketing
02/27/08 - TyRx Pharma, Inc. Raises $25 Million in Private Financing
01/17/08 - TyRx Pharma, Inc. Announces Food and Drug Administration (FDA) 510(k) Clearance of the AIGISRX™ Cardiac Rhythm Medical Device (CRMD) Anti-Bacterial Envelope, an Innovative Mesh Envelope Designed to Immobilize and Reduce Bacterial Infection of a Pacemaker or Implantable Cardioverter Defibrillator (ICD) When Implanted in the Body
12/11/07 -
TyRx Pharma, Inc., Announces the Appointment of
Robert M. (Bob) Mattioli as Vice President, Commercial Development
10/24/07 - TyRx Pharma, Inc. Announces Presentation of Results to Benefit Women with Breast Implants (In-Vivo Efficacy Study Regarding AIGISRx DEB) at the Plastic Surgery 2007 Meeting on October, 28 2007 in Baltimore, MD
08/09/07 - TyRx Pharma, Inc., Announces the Hiring of Mark Citron as Vice President,
Clinical and Regulatory Affairs
03/19/07 - TyRx Pharma, Inc. Announces Presentation of the Results of an In-Vivo Efficacy Study Regarding PIVIT™ CRM at the Heart Rhythm Society Meeting
02/26/07 - TyRx Pharma, Inc., and JFC Technologies Signs Manufacturing Supply Agreement
01/29/07 - TyRx Pharma, Inc. Announces Strategic Alliance
10/16/06 - TyRx Pharma, Inc. Announces Submission of a Premarket Application for PIVIT™ CRM, an Innovative Mesh Pouch Designed To Hold and Reduce Bacterial Colonization of a Pacemaker or Implantable Defibrillator Pulse Generator (ICD) When Implanted In the Body
07/24/06 -TyRx Pharma, Inc., Announces FDA Clearance of PIVIT™ AB, a Novel Antimicrobial-
Coated Surgical Mesh
06/20/06 -
TyRx Pharma, Inc., and Forrest T. Smith, PhD, Awarded the 2006 Fruchaud Prize for Best Scientific Poster Presentation during the 3rd International Hernia Congress
05/15/06 - TyRx Pharma, Inc., Announces the Election of Dr. Mason Diamond as Industry Representative to the FDA Advisory Committee on Dental Products
03/06 – TyRx Pharma Inc. Start-ups Across healthcare\
02/27/06 – Physicians Weekly/Bioresorbable Polymer Surgical Mesh
01/30/06 – TyRx Pharma, Inc., Announces the Signing of Exclusive License Agreement
01/23/06 – TyRx Says Combination Products Offer Greater Opportunity than Drug
Delivery
01/17/06 – TyRx Announces FDA 510(K) Filling For New Antibiotic
Eluting Surgical Mesh
01/09/06 – TyRx Pharma’s Anesthetic Coated Surgical Mesh Combination Product Assigned
to “Device” Center at FDA
01/03/06 – TyRx Announces FDA 510(k) Clearance for New Surgical Mesh
11/7/05 – TyRx Pharma, Inc. Joins the Combination Products Coalition
10/17/05 – TyRx Pharma, Inc. Joins the Combination Products Coalition
05/09/05 – TyRx Pharma, Inc. Announces Two Senior Staff
Additions
04/20/05 – TyRx Pharma, Inc. Announces Appointments
to Its Board of Directors
02/05 – Interview with Bill Edelman
01/05 – TyRx Pharma, Inc. Announces Equity Investment
by Boston Scientific Corporation
1/7/05 – Closed $4.0M Series D Financing Round
9/22/04 – Restated License Agreement for core technology
with Rutgers, The State University of New Jersey
9/15/04 – Relocated to Monmouth Junction 7,200ft2
Facility
8/12/04 – Closed $1.5M Interim Financing Round |
